Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 22394344)

1.

Oxidative stress and cardiac hypertrophy: a review.

Maulik SK, Kumar S.

Toxicol Mech Methods. 2012 Jun;22(5):359-66. doi: 10.3109/15376516.2012.666650. Epub 2012 Mar 20. Review.

PMID:
22394344
2.

Desmodium gangeticum (Linn.) DC. exhibits antihypertrophic effect in isoproterenol-induced cardiomyoblasts via amelioration of oxidative stress and mitochondrial alterations.

Sankar V, Pangayarselvi B, Prathapan A, Raghu KG.

J Cardiovasc Pharmacol. 2013 Jan;61(1):23-34. doi: 10.1097/FJC.0b013e3182756ad3.

PMID:
23052030
3.

Oxidative stress and heart failure.

Tsutsui H, Kinugawa S, Matsushima S.

Am J Physiol Heart Circ Physiol. 2011 Dec;301(6):H2181-90. doi: 10.1152/ajpheart.00554.2011. Epub 2011 Sep 23. Review.

4.

Protective effect of Boerhaavia diffusa L. against mitochondrial dysfunction in angiotensin II induced hypertrophy in H9c2 cardiomyoblast cells.

Prathapan A, Vineetha VP, Raghu KG.

PLoS One. 2014 Apr 30;9(4):e96220. doi: 10.1371/journal.pone.0096220. eCollection 2014.

5.

Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways.

Li HL, Huang Y, Zhang CN, Liu G, Wei YS, Wang AB, Liu YQ, Hui RT, Wei C, Williams GM, Liu DP, Liang CC.

Free Radic Biol Med. 2006 May 15;40(10):1756-75.

PMID:
16767845
6.

NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure.

Murdoch CE, Zhang M, Cave AC, Shah AM.

Cardiovasc Res. 2006 Jul 15;71(2):208-15. Epub 2006 Mar 27. Review.

7.

Allicin protects against cardiac hypertrophy and fibrosis via attenuating reactive oxygen species-dependent signaling pathways.

Liu C, Cao F, Tang QZ, Yan L, Dong YG, Zhu LH, Wang L, Bian ZY, Li H.

J Nutr Biochem. 2010 Dec;21(12):1238-50. doi: 10.1016/j.jnutbio.2009.11.001. Epub 2010 Feb 25.

PMID:
20185286
8.

Oxidative stress and heart failure.

Byrne JA, Grieve DJ, Cave AC, Shah AM.

Arch Mal Coeur Vaiss. 2003 Mar;96(3):214-21. Review.

PMID:
12722552
9.

Involvement of NADPH oxidases in cardiac remodelling and heart failure.

Sirker A, Zhang M, Murdoch C, Shah AM.

Am J Nephrol. 2007;27(6):649-60. Epub 2007 Sep 27. Review.

PMID:
17901689
10.

Targeting calcium and the mitochondria in prevention of pathology in the heart.

Viola HM, Hool LC.

Curr Drug Targets. 2011 May;12(5):748-60. Review.

PMID:
21291390
11.

Additive beneficial effects of amlodipine and atorvastatin in reversing advanced cardiac hypertrophy in elderly spontaneously hypertensive rats.

Lu JC, Cui W, Zhang HL, Liu F, Han M, Liu DM, Yin HN, Zhang K, Du J.

Clin Exp Pharmacol Physiol. 2009 Nov;36(11):1110-9. doi: 10.1111/j.1440-1681.2009.05198.x. Epub 2009 Apr 27.

PMID:
19413592
12.

Chronic cocaine-induced cardiac oxidative stress and mitogen-activated protein kinase activation: the role of Nox2 oxidase.

Fan L, Sawbridge D, George V, Teng L, Bailey A, Kitchen I, Li JM.

J Pharmacol Exp Ther. 2009 Jan;328(1):99-106. doi: 10.1124/jpet.108.145201. Epub 2008 Oct 24.

13.

NADPH oxidase and cardiac failure.

Kuroda J, Sadoshima J.

J Cardiovasc Transl Res. 2010 Aug;3(4):314-20. doi: 10.1007/s12265-010-9184-8. Epub 2010 Mar 31. Review.

14.

Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.

Montezano AC, Touyz RM.

Can J Cardiol. 2012 May;28(3):288-95. doi: 10.1016/j.cjca.2012.01.017. Epub 2012 Mar 23. Review.

PMID:
22445098
15.
16.

Chronic hydrogen-rich saline treatment reduces oxidative stress and attenuates left ventricular hypertrophy in spontaneous hypertensive rats.

Yu YS, Zheng H.

Mol Cell Biochem. 2012 Jun;365(1-2):233-42. doi: 10.1007/s11010-012-1264-4. Epub 2012 Feb 18.

PMID:
22350760
17.

Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species.

Redout EM, Wagner MJ, Zuidwijk MJ, Boer C, Musters RJ, van Hardeveld C, Paulus WJ, Simonides WS.

Cardiovasc Res. 2007 Sep 1;75(4):770-81. Epub 2007 May 17.

18.

Role of oxidative stress in cardiac hypertrophy and remodeling.

Takimoto E, Kass DA.

Hypertension. 2007 Feb;49(2):241-8. Epub 2006 Dec 26. Review. No abstract available.

19.

Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared?

Balakumar P, Jagadeesh G.

Pharmacol Res. 2010 Nov;62(5):365-83. doi: 10.1016/j.phrs.2010.07.003. Epub 2010 Jul 17. Review.

PMID:
20643208
20.

Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS production.

Wu R, Wyatt E, Chawla K, Tran M, Ghanefar M, Laakso M, Epting CL, Ardehali H.

EMBO Mol Med. 2012 Jul;4(7):633-46. doi: 10.1002/emmm.201200240. Epub 2012 Apr 20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk